Lawrence Blacher, M.D., Memorial Lecture: Advancing the Fight Against Cardiac Amyloidosis: A 2026 Update - Takeaways - MDSpire

Lawrence Blacher, M.D., Memorial Lecture: Advancing the Fight Against Cardiac Amyloidosis: A 2026 Update

Please join us to hear Omar F. Abou-Ezzeddine, M.D.C.M., M.S., at the Lawrence Blacher, M.D., Memorial Lecture, where he will provide a 2026 update on amyloid cardiomyopathy, highlighting current diagnostic strategies, emerging therapies, and practical approaches to patient care.

  • By

  • March 20, 2026

  • 1 min

Share

  • 1

    Cardiac amyloidosis is a significant and treatable cause of heart failure and cardiomyopathy.

  • 2

    Recent advancements in imaging, biomarkers, and therapies have improved diagnosis and management of cardiac amyloidosis.

  • 3

    Early recognition of cardiac amyloidosis is crucial for effective treatment and patient outcomes.

  • 4

    The 2026 update will cover current diagnostic strategies and emerging therapies for amyloid cardiomyopathy.

  • 5

    Participants will learn to apply supportive management strategies for patients with amyloid cardiomyopathy.

Original Source(s)

Lawrence Blacher, M.D., Memorial Lecture: Advancing the Fight Against Cardiac Amyloidosis: A 2026 Update

  • by

  • March 20, 2026

Related Content

Quantitative CT assessment of intrathoracic visceral fat depots and their association with incident heart failure in asymptomatic adults

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

Functional consequences of diminished myocardial oxygen delivery per beat in experimental heart failure